CN105434793A - Composition for treating psoriasis pustulose and preparation method for composition - Google Patents
Composition for treating psoriasis pustulose and preparation method for composition Download PDFInfo
- Publication number
- CN105434793A CN105434793A CN201610023124.0A CN201610023124A CN105434793A CN 105434793 A CN105434793 A CN 105434793A CN 201610023124 A CN201610023124 A CN 201610023124A CN 105434793 A CN105434793 A CN 105434793A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- stir
- minute
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 64
- 238000002360 preparation method Methods 0.000 title claims description 25
- 201000004681 Psoriasis Diseases 0.000 title abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 24
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 20
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000003814 drug Substances 0.000 claims description 69
- 206010037575 Pustular psoriasis Diseases 0.000 claims description 43
- 229940079593 drug Drugs 0.000 claims description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 208000001840 Dandruff Diseases 0.000 claims description 24
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 22
- 241000628997 Flos Species 0.000 claims description 21
- 238000001914 filtration Methods 0.000 claims description 21
- 241001116389 Aloe Species 0.000 claims description 19
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims description 19
- 235000011399 aloe vera Nutrition 0.000 claims description 19
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 19
- 239000002775 capsule Substances 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 14
- 235000019991 rice wine Nutrition 0.000 claims description 13
- 206010053615 Thermal burn Diseases 0.000 claims description 11
- 239000012267 brine Substances 0.000 claims description 11
- 229910052742 iron Inorganic materials 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 11
- 238000002791 soaking Methods 0.000 claims description 11
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 claims description 11
- 239000000052 vinegar Substances 0.000 claims description 11
- 235000021419 vinegar Nutrition 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- 235000013339 cereals Nutrition 0.000 claims description 9
- 238000012545 processing Methods 0.000 claims description 8
- 238000005520 cutting process Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 22
- 208000002193 Pain Diseases 0.000 abstract description 14
- 230000036407 pain Effects 0.000 abstract description 14
- 208000003251 Pruritus Diseases 0.000 abstract description 11
- 208000024891 symptom Diseases 0.000 abstract description 9
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 abstract description 6
- 240000000233 Melia azedarach Species 0.000 abstract description 5
- 235000000177 Indigofera tinctoria Nutrition 0.000 abstract description 4
- 229940097275 indigo Drugs 0.000 abstract description 4
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract description 2
- 208000010201 Exanthema Diseases 0.000 abstract description 2
- 241000218682 Pseudolarix amabilis Species 0.000 abstract description 2
- 201000005884 exanthem Diseases 0.000 abstract description 2
- 230000007803 itching Effects 0.000 abstract description 2
- 206010037844 rash Diseases 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000218176 Corydalis Species 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 241000612118 Samolus valerandi Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 206010037888 Rash pustular Diseases 0.000 description 15
- 208000029561 pustule Diseases 0.000 description 15
- 206010000496 acne Diseases 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 231100000614 poison Toxicity 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 10
- 201000004624 Dermatitis Diseases 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 208000015181 infectious disease Diseases 0.000 description 9
- 208000006820 Arthralgia Diseases 0.000 description 8
- 239000003440 toxic substance Substances 0.000 description 8
- 206010015150 Erythema Diseases 0.000 description 6
- 206010040844 Skin exfoliation Diseases 0.000 description 6
- 208000010668 atopic eczema Diseases 0.000 description 6
- 231100000321 erythema Toxicity 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 206010040882 skin lesion Diseases 0.000 description 6
- 231100000444 skin lesion Toxicity 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 230000035618 desquamation Effects 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 208000002874 Acne Vulgaris Diseases 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 4
- 208000033809 Suppuration Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- YJGVMLPVUAXIQN-UHFFFAOYSA-N epipodophyllotoxin Natural products COC1=C(OC)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YJGVMLPVUAXIQN-UHFFFAOYSA-N 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 210000003026 hypopharynx Anatomy 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 208000002399 aphthous stomatitis Diseases 0.000 description 3
- 230000000721 bacterilogical effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 208000023368 generalized pustular psoriasis Diseases 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- YJGVMLPVUAXIQN-XVVDYKMHSA-N podophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-XVVDYKMHSA-N 0.000 description 3
- 229960001237 podophyllotoxin Drugs 0.000 description 3
- YVCVYCSAAZQOJI-UHFFFAOYSA-N podophyllotoxin Natural products COC1=C(O)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YVCVYCSAAZQOJI-UHFFFAOYSA-N 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- CRDNMYFJWFXOCH-YPKPFQOOSA-N (3z)-3-(3-oxo-1h-indol-2-ylidene)-1h-indol-2-one Chemical compound N/1C2=CC=CC=C2C(=O)C\1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-YPKPFQOOSA-N 0.000 description 2
- HSSDVCMYTACNSM-UHFFFAOYSA-N 5-hydroxy-9-(3,4,5-trimethoxyphenyl)-6h-[2]benzofuro[5,6-f][1,3]benzodioxol-8-one Chemical compound COC1=C(OC)C(OC)=CC(C=2C3=CC=4OCOC=4C=C3C(O)=C3COC(=O)C3=2)=C1 HSSDVCMYTACNSM-UHFFFAOYSA-N 0.000 description 2
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000003322 Coinfection Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000385515 Dysosma delavayi Species 0.000 description 2
- 241000893564 Dysosma pleiantha Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 241000334154 Isatis tinctoria Species 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 241001529246 Platymiscium Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 206010057190 Respiratory tract infections Diseases 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 240000005498 Setaria italica Species 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 210000000589 cicatrix Anatomy 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000003862 glucocorticoid Substances 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- -1 luteolin glycosides Chemical class 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000002252 panizo Nutrition 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- GEHGAWHOBGXBGC-MIUHORAWSA-N (1s,3r,5r,7r,8s,9s,10s,12r,13s,14s,17r)-17-(furan-3-yl)-1,7,20-trihydroxy-4,8,13-trimethyl-11,15-dioxohexadecahydro-4,10-(methanooxymethano)cyclopenta[a]phenanthrene-3,12-diyl diacetate Chemical compound C=1([C@@H]2CC(=O)[C@H]3[C@]4(C)[C@H](O)C[C@H]5C6(C)C(O)OC[C@]5([C@H]4C(=O)[C@H](OC(C)=O)[C@]32C)[C@@H](O)C[C@H]6OC(=O)C)C=COC=1 GEHGAWHOBGXBGC-MIUHORAWSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- JOQZKEFBHIMDMX-UHFFFAOYSA-N 12alpha-hydroxyamoorastatone Natural products CC(=O)OC1CC(O)C23COC(O)C1(C)C2CC(O)C4(C)C5C(=O)CC(c6cocc6)C5(C)C(O)C(=O)C34 JOQZKEFBHIMDMX-UHFFFAOYSA-N 0.000 description 1
- ZPKCJXWKXAHCSX-UHFFFAOYSA-N 2,3,5,6-tetraphenylpyrazine Chemical compound C1=CC=CC=C1C1=NC(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)N=C1C1=CC=CC=C1 ZPKCJXWKXAHCSX-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000207965 Acanthaceae Species 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000270955 Achnatherum calamagrostis Species 0.000 description 1
- 244000296912 Ageratum conyzoides Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- CRDNMYFJWFXOCH-BUHFOSPRSA-N Couroupitine B Natural products N\1C2=CC=CC=C2C(=O)C/1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-BUHFOSPRSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- ZGLXUQQMLLIKAN-UHFFFAOYSA-N Deoxypicropodophyllin Natural products COC1=C(OC)C(OC)=CC(C2C3=CC=4OCOC=4C=C3CC3C2C(OC3)=O)=C1 ZGLXUQQMLLIKAN-UHFFFAOYSA-N 0.000 description 1
- 206010012455 Dermatitis exfoliative Diseases 0.000 description 1
- VMEJANRODATDOF-UHFFFAOYSA-N Diphyllin Chemical compound C1=C2OCOC2=CC(C=2C=3C(=O)OCC=3C(O)=C3C=C(C(=CC3=2)OC)OC)=C1 VMEJANRODATDOF-UHFFFAOYSA-N 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 241000893563 Dysosma Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- SQOFOICCLANSLR-UHFFFAOYSA-N Echinatin Natural products CC(C)C(O)(C(C)O)C(=O)OCC1=CCN2CCC(O)C12C SQOFOICCLANSLR-UHFFFAOYSA-N 0.000 description 1
- 206010014418 Electrolyte imbalance Diseases 0.000 description 1
- 206010014568 Empyema Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 241000218228 Humulus Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000013038 Hypocalcemia Diseases 0.000 description 1
- 208000034767 Hypoproteinaemia Diseases 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- ISCQYPPCSYRZOT-UHFFFAOYSA-N Isopicropodophyllin Natural products COC1=C(OC)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(=O)C3C2C(OC3)=O)=C1 ISCQYPPCSYRZOT-UHFFFAOYSA-N 0.000 description 1
- GEHGAWHOBGXBGC-UHFFFAOYSA-N Isotoosendanin Natural products CC(=O)OC1CC(O)C2(C3C(=O)C(OC(C)=O)C45C)COC(O)C1(C)C2CC(O)C3(C)C4C(=O)CC5C=1C=COC=1 GEHGAWHOBGXBGC-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000146029 Lindera aggregata Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241000195954 Lycopodium clavatum Species 0.000 description 1
- 241000276489 Merlangius merlangus Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- OBIOZWXPDBWYHB-UHFFFAOYSA-N Nobiletin Natural products C1=CC(OC)=CC=C1C1=C(OC)C(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 OBIOZWXPDBWYHB-UHFFFAOYSA-N 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000006187 Onycholysis Diseases 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 206010033474 Pain of skin Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 241000382362 Persicaria tinctoria Species 0.000 description 1
- 241000237636 Pheretima Species 0.000 description 1
- ISCQYPPCSYRZOT-BKTGTZMESA-N Podophyllotoxone Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3C(=O)[C@@H]3[C@@H]2C(OC3)=O)=C1 ISCQYPPCSYRZOT-BKTGTZMESA-N 0.000 description 1
- 241000133806 Pogonarthria squarrosa Species 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 241001192930 Pustula Species 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000258712 Runaria Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 241001643409 Sinomenium acutum Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000123725 Sophora tonkinensis Species 0.000 description 1
- 208000035286 Spontaneous Remission Diseases 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 206010061372 Streptococcal infection Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- NAHTXVIXCMUDLF-DUJPAFNYSA-N Toosendanin Natural products O=C(O[C@H]1C(=O)[C@H]2[C@@](C)([C@H](O)C[C@H]3[C@@]4(C)[C@H](O)OC[C@@]23[C@@H](O)C[C@H]4OC(=O)C)[C@@]23[C@]1(C)[C@H](c1cocc1)C[C@H]2O3)C NAHTXVIXCMUDLF-DUJPAFNYSA-N 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- QZHPTGXQGDFGEN-UHFFFAOYSA-N chromene Chemical compound C1=CC=C2C=C[CH]OC2=C1 QZHPTGXQGDFGEN-UHFFFAOYSA-N 0.000 description 1
- 150000008371 chromenes Chemical class 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- ZGLXUQQMLLIKAN-SVIJTADQSA-N deoxypodophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3C[C@@H]3[C@@H]2C(OC3)=O)=C1 ZGLXUQQMLLIKAN-SVIJTADQSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- RFXQCUDAHXPYOF-UHFFFAOYSA-N diphyllin Natural products COc1cc2c(c3ccc4OCOc4c3)c5C(=O)OCc5c(O)c2cc1O RFXQCUDAHXPYOF-UHFFFAOYSA-N 0.000 description 1
- 229960002819 diprophylline Drugs 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- QJKMIJNRNRLQSS-WEVVVXLNSA-N echinatin Chemical compound COC1=CC(O)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1 QJKMIJNRNRLQSS-WEVVVXLNSA-N 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 208000016253 exhaustion Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000000705 hypocalcaemia Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 208000005005 intertrigo Diseases 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- SFVVQRJOGUKCEG-UHFFFAOYSA-N isoechinatine Natural products C1CC(O)C2C(COC(=O)C(O)(C(C)O)C(C)C)=CCN21 SFVVQRJOGUKCEG-UHFFFAOYSA-N 0.000 description 1
- CRDNMYFJWFXOCH-UHFFFAOYSA-N isoindigotin Natural products N1C2=CC=CC=C2C(=O)C1=C1C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-UHFFFAOYSA-N 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- QJKMIJNRNRLQSS-UHFFFAOYSA-N loureirin C Natural products COC1=CC(O)=CC=C1C=CC(=O)C1=CC=C(O)C=C1 QJKMIJNRNRLQSS-UHFFFAOYSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000001037 metacarpus Anatomy 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- MRIAQLRQZPPODS-UHFFFAOYSA-N nobiletin Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 MRIAQLRQZPPODS-UHFFFAOYSA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940100691 oral capsule Drugs 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- YJGVMLPVUAXIQN-HAEOHBJNSA-N picropodophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-HAEOHBJNSA-N 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- GOHMRMDXUXWCDQ-UHFFFAOYSA-N pseudolaric acid B Natural products CC(=O)OC12CCC(C)=CCC11C(=O)OC(C)(C=CC=C(C)C(O)=O)C2CC1 GOHMRMDXUXWCDQ-UHFFFAOYSA-N 0.000 description 1
- VDGOFNMYZYBUDT-YDRCMHEVSA-N pseudolaric acid b Chemical compound C([C@@]12OC(C)=O)CC(C(=O)OC)=CC[C@@]11C(=O)O[C@](C)(\C=C\C=C(/C)C(O)=O)[C@@H]2CC1 VDGOFNMYZYBUDT-YDRCMHEVSA-N 0.000 description 1
- VDGOFNMYZYBUDT-UHFFFAOYSA-N pseudolarix acid B Natural products CC(=O)OC12CCC(C(=O)OC)=CCC11C(=O)OC(C)(C=CC=C(C)C(O)=O)C2CC1 VDGOFNMYZYBUDT-UHFFFAOYSA-N 0.000 description 1
- 230000001185 psoriatic effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 description 1
- 229910052683 pyrite Inorganic materials 0.000 description 1
- 239000011028 pyrite Substances 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 150000003873 salicylate salts Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000015339 staphylococcus aureus infection Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- NAHTXVIXCMUDLF-RFNFAWMESA-N toosendanin Chemical compound C=1([C@H]2[C@]3(C)[C@@H](OC(C)=O)C(=O)[C@H]4[C@@]([C@@]53O[C@@H]5C2)(C)[C@H](O)C[C@H]2[C@@]3(C)[C@H](O)OC[C@]24[C@@H](O)C[C@H]3OC(=O)C)C=COC=1 NAHTXVIXCMUDLF-RFNFAWMESA-N 0.000 description 1
- 239000008488 toosendanin Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000000051 wattle Anatomy 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
- A61K36/855—Clerodendrum, e.g. glorybower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a composition for treating psoriasis pustulose. The composition is prepared from the following main raw materials in weight proportion: 4.5 to 9 parts of golden larch bark, 4.5 to 9 parts of chinaberry bark and root-bark, 3 to 6 parts of honeysuckle, 3 to 6 parts of cassia twig, 3 to 6 parts of natural indigo, 4.5 to 9 parts of Mongolian dandelion herb, 0.9 to 1.5 parts of talcum powder, 9 to 30 parts of indigowoad leaf (preferably 9.5 to 29.5 parts of indigowoad leaf), 9 to 12 parts of herba rhodiolae, 6 to 12 parts of spreading hedyotis herb, 6 to 12 parts of caulis spatholobi, 6 to 12 parts of poria and 6 to 15 parts of bunge corydalis herb. The composition for treating psoriasis pustulose disclosed by the invention is capable of effectively relieving rash symptoms caused by psoriasis pustulose, has the effects of relieving itching and stopping pain, has a very good therapeutic action on psoriasis pustulose, is safe and effective and has no side effects.
Description
Technical field
The invention discloses a kind of compositions, especially treat the composition and method of making the same of psoriasis pustulosa.Belong to traditional Chinese medicine field.
Background technology
Pustule (pustule) is a limitation epidermis cavity protuberance, includes muddy pus.System is primary in skin and is formed by papulovesicle differentiation.The pustule size depth not etc., can not have inflammatory blush around, become after shallow pustule is dry pus crusts more after do not stay cicatrix, pustule more deeply can be formed ulcer more after can stay cicatrix.
The cause of disease: the reason occurred as psoriasis pustulosa, still unclear at present, pathogenesis is comparatively complicated, and risk factor is also more, but generally stimulates relevant with medication.Especially in recent years, cause the case of generalized pustular psoriasis to have due to irregular application corticosteroid treatment psoriasis vulgaris and increase trend.As life-time service external glucocorticoid, Salicylates, sun exposure etc.Also after it was observed that primary disease betides upper respiratory tract streptococcal infection, thus think again may with infection relevant.But be not direct infection skin, but the extraordinary reaction of the one of health.In addition, the pustule of this pustule and real bacteriological infection is different.The pustule of bacteriological infection is comparatively large, and isolate, be dispersed in distribution, comparison sheet is shallow, and easily rotten to the corn, there is pus crusts on surface, the clinical impetigo being common in child.The aseptic pustule of psoriasis pustulosa is then less, dense distribution, more deeply, not easily forms rotten to the corn face, has desquamation after pustule is withered.Therefore, psoriasis pustulosa is not bacteriological infection, but a kind of aseptic pustule, and the traditional Chinese medical science thinks the deficiecny of liver-YIN of its basic pathogenic factor or patient.The course of disease of psoriasis pustulosa is longer, and treatment lacks the single dose medicine of determined curative effect, although drug combination can symptom management, some west side effects of pharmaceutical drugs also should not be underestimated, and are easy to recurrence, especially palmar and plantar pustula psoriasis after drug withdrawal.Therefore, Traditional Chinese Medicine experts reminds patient, should comprehensively analyze the state, patient's condition to the treatment of psoriasis pustulosa, removes possible risk factor, avoids pursuing short term effect merely and ignore Western medicine side effect and late result, note locally with the complementarity etc. of systematic treating.
Clinical manifestation: the 1. type that generalized pustular psoriasis is the heaviest clinically, more rare, etiology unknown, in external dripping of irritant drugs, infection, application glucocorticoid or immunosuppressant process, drug withdrawal etc. is precipitating factor suddenly.Fall ill hurried, the high heat of sustainable a few days tension and relaxation, companion's general malaise, weak and arthroncus, erythema occurs suddenly general send out shallow the aseptic pimple of yellow-white, syringe needle, to foxtail millet grain size, is just small pieces, is fused in " pus lake " later, in several weeks can diffusivity distribution whole body, often there is intertrigo, incrustation in pleat portion, the erythema around pustule is often expanded and is fused into the change of erythroderma sample, the visible pimple of mucosa, lingual surface often has comparatively zanjon stricture of vagina, claims fluted tongue.Comparatively can occur together the course of disease finger tip atrophy, myasthenia, total white blood cells increase, hypocalcemia, erythrocyte sedimentation rate speed by elder, even can occur serious systemic lesion and secondary infection.Short-term heating, pustule are often in cyclic recurrence, and spontaneous remission after last for days to several weeks, the general rubescent speckle desquamation of whole body, become Folium Styracis Suberifoliae glass recurrent exerbation like this, cause patient's hypoproteinemia, systemic conditions is poor, prognosis mala.Generalized pustular psoriasis is the system damage such as concurrent liver, kidney usually, also can because of secondary infection, electrolyte disturbance or exhaustion threat to life.2. limitation psoriasis pustulosa erythra is limited to palm and the sufficient sole of the foot, symmetrical.Metacarpus skin lesion onset is in large hypothenar, and later skin lesion gradually expands to the centre of the palm, the back of the hand and finger, and sufficient sole of the foot portion is apt to occur in the middle part of the sole of the foot and inner side, and erythra is that in symmetry erythema, faint yellow syringe needle, to the large pimple of foxtail millet grain, not easily breaks in groups.After about 1-2 weeks, there is new bleb in groups in dry, the incrustation of pustule and desquamation repeatedly under squama, therefore the different times infringement such as visible pustule, incrustation, desquamation on same skin lesion, recurrent exerbation like this, time light time weigh, prolongedly not heal.The pathological changes of patient Chang Banjia, first has pitting, traverse furrow, vertical ridge, first are muddy, an empyema under onycholysis and first.
In the method for existing Chinese medicine psoriasis pustulosa, application publication number CN104435914A(application number 201410659017.8) patent discloses a kind of Chinese medicine for the treatment of psoriasis pustulosa, it is characterized in that the Chinese medicine preparation be made up of the medical material of following weight proportion: Rhizoma Smilacis Glabrae 50-100 part, Rhizoma Smilacis Scobinicaulis 20-30 part, Radix Polygoni Multiflori 20-30 part, Radix Rehmanniae 10-15 part, Herba Plantaginis 10-15 parts, Rhizoma Acori Graminei 10-15 part, Sinomenium acutum 10-15 part, Herba Spirodelae 10-15 part, Radix Glycyrrhizae 6-9 part, Authorization Notice No. CN102716198B(application number 201210052153.1) disclose one and treat psoriatic medicine, it is characterized in that crude drug is: Cortex Meliae, Radix Sophorae Flavescentis, Herba Ranunculi Japonici, salicylic acid, boric acid, benzoic acid, Herba polygoni hydropiperis, the consumption of each crude drug is: Cortex Meliae 15 ~ 25 parts, Radix Sophorae Flavescentis 10 ~ 20 parts, Herba Ranunculi Japonici 40 ~ 60 parts, salicylic acid 10 ~ 20 parts, boric acid 15 ~ 25 parts, 3 ~ 8 parts, benzoic acid, Herba polygoni hydropiperis 7 ~ 13 parts, also containing ethanol or rice wine or Chinese liquor, preparation method is: heat to 80 ~ 90 DEG C by ethanol or rice wine or Chinese liquor, soaks crude drug more than 1 hour, and batching is expensive and be not easy to obtain, and preparation method is complicated, and it is external-applied ointment, cures the symptoms, not the disease, and cannot reach the object of radical cure.
Summary of the invention
For the present situation of existing treatment psoriasis pustulosa deficiency, an object of the present invention is to provide a kind of compositions for the treatment of psoriasis pustulosa, there is feature easy to operate, evident in efficacy, and it adopts Chinese crude drug comparatively common in the localities as raw material, with low cost.
Another object of the present invention is just to provide the preparation method of above-mentioned treatment psoriasis pustulosa.
Above-mentioned purpose of the present invention is achieved through the following technical solutions:
A kind of compositions for the treatment of psoriasis pustulosa, take off the primary raw material stating weight proportion to be prepared from: Cortex Pseudolaricis 4.5-9 part, Cortex Meliae 4.5-9 part, Flos Lonicerae 3-6 part, Ramulus Cinnamomi 3-6 part, Indigo Naturalis 3-6 part, Herba Taraxaci 4.5-9 part, Pulvis Talci 0.9-1.5 part, Folium Isatidis 9-30 part is (preferred, Folium Isatidis 9.5-29.5 part), Radix Rhodiolae 9-12 part, Herba Hedyotidis Diffusae 6-12 part, Caulis Spatholobi 6-12 part, Poria 6-12 part, Herba Violae 6-15 part, Fructus Toosendan 9-15 part, Herba Menthae 9-15 part, Radix Sophorae Tonkinensis 4-9 part, Radix et Rhizoma Dysosmatis 3-12 part, Herba Agerati Conyzoidis 9-15 part, Aloe juice 20-40 part.
Treat a compositions for psoriasis pustulosa, preferred proportioning, take off the primary raw material stating weight proportion and be prepared from: Cortex Pseudolaricis 5-8 part, Cortex Meliae 5-8 part, Flos Lonicerae 3.5-5 part, Ramulus Cinnamomi 3.5-5 part, Indigo Naturalis 3.5-5 part, Herba Taraxaci 5-8 part, Pulvis Talci 1.0-1.4 part, Folium Isatidis 12-25 part, Radix Rhodiolae 9.5-11 part, Herba Hedyotidis Diffusae 7-11 part, Caulis Spatholobi 7-11 part, Poria 7-11 part, Herba Violae 8-12 part, Fructus Toosendan 10-13 part, Herba Menthae 10-14 part, Radix Sophorae Tonkinensis 5-8 part, Radix et Rhizoma Dysosmatis 4-10 part, Herba Agerati Conyzoidis 10-14 part, Aloe juice 25-35 part.
Treat a compositions for psoriasis pustulosa, more preferably proportioning, take off the primary raw material stating weight proportion and be prepared from: Cortex Pseudolaricis 7 parts, Cortex Meliae 7 parts, Flos Lonicerae 4 parts, Ramulus Cinnamomi 4 parts, Indigo Naturalis 4 parts, Herba Taraxaci 6 parts, Pulvis Talci 1.2 parts, Folium Isatidis 20 parts, Radix Rhodiolae 10 parts, Herba Hedyotidis Diffusae 9 parts, Caulis Spatholobi 8 parts, 9 parts, Poria, Herba Violae 10 parts, Fructus Toosendan 12 parts, Herba Menthae 12 parts, Radix Sophorae Tonkinensis 6 parts, Radix et Rhizoma Dysosmatis 6 parts, Herba Agerati Conyzoidis 12 parts, Aloe juice 30 parts.
Treat a preparation method of composition for psoriasis pustulosa, preparation process is as follows:
1. Cortex Pseudolaricis, Cortex Meliae, Flos Lonicerae, Ramulus Cinnamomi, Herba Taraxaci, Folium Isatidis and Herba Menthae are together shredded, 14-26 minute is soaked with light salt brine, filter, the hot water of soaked crude drug 90-100 DEG C scalds twice, is placed in preheated container, stir-fry 2-6 minute repeatedly, cease fire, put into crude drug weight 0.2-0.4 vinegar doubly, mixing, continue the 5-12 minute that stir-fries, drying in the air coolly grinds to form smalls to cross 80-120 mesh sieve stand-by;
2. by step 1. gained smalls and Indigo Naturalis and Pulvis Talci mix and add Aloe juice, mix thoroughly clockwise, bottle and obtain medicine for external use;
3. with the warm water soaking 33-44 minute of 30-40 DEG C in container Radix Rhodiolae, Herba Hedyotidis Diffusae, Caulis Spatholobi, Poria, Herba Violae, Fructus Toosendan, Radix Sophorae Tonkinensis, Radix et Rhizoma Dysosmatis and Herba Agerati Conyzoidis being placed in non iron, decoct twice, each is all first be fried open with high heat, turning 10-20 minute at a simmer, filter, twice filtrate mixing, filtering residue is stand-by;
4. by step 3. gained filtering residue be placed in transparent vessel, add raw material weight 2-4 rice wine doubly, brewed 2-4 hour, filter, filtering residue is fried to crisp, grind to form smalls and step 3. gained filtrate mix, decoct and stir into thick paste and put into Mel and stir evenly, repeatedly rub, be twisted into medicated strip, cutting in bulk, is kneaded into grain, is prepared into capsule namely obtains oral medicine according to the processing technique subpackage of capsule.
Above-mentioned preparation method, 1. step soaks 18-22 minute with light salt brine, filters, and the hot water of soaked crude drug 93-98 DEG C scalds twice (preferably soak 20 minutes with light salt brine, filter, the soaked crude drug hot water of 95 DEG C scalds twice).
Above-mentioned preparation method, 1. step stir-fries 3-5 minute repeatedly, ceases fire, and puts into crude drug weight 0.25-0.35 vinegar doubly (preferably repeatedly stir-fry 4 minutes, cease fire, put into the vinegar of crude drug weight 0.3 times).
Above-mentioned preparation method, is characterized in that, 1. step continues the 7-10 minute that stir-fries, and the cool smalls that grinds to form that dries in the air crosses 90-110 mesh sieve stand-by (preferably continue to stir-fry 8 minutes, dry in the air cool grind to form smalls to cross 100 mesh sieves stand-by).
Above-mentioned preparation method, is characterized in that, with 33-38 DEG C warm water soaking 38-40 minute (being preferably placed in the interior warm water soaking with 35 DEG C of the container of non iron 39 minutes) in the container that 3. step is placed in non iron.
Above-mentioned preparation method, is characterized in that, 3. step is all first be fried open with high heat at every turn, is turning 13-18 at a simmer minute (be all preferably first be fried open with high heat at every turn, turning 15 minutes at a simmer).
Above-mentioned preparation method, is characterized in that, 4. step adds raw material weight 2.5-3.5 rice wine doubly, brewed 2.5-3.5 hour (preferably adding the rice wine of raw material weight 3 times, brewed 3 hours).
Said composition, to the Be very effective of psoriasis pustulosa, not only has antipruritic, that peeling rash etc. controls table disease effect, fundamentally thoroughly can also treat psoriasis pustulosa, and can for the different reason determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs of psoriasis pustulosa.The local common medical material of multiselect of the present invention, cheap, alleviate the financial burden of patient.
Treat a compositions for psoriasis pustulosa, the pharmacological effect of each crude drug is respectively:
Cortex Pseudolaricis: have another name called arhat Cortex Pini Massonianae, wattle skin, pseudolaricis,cortex is root bark and the near root bark of Pinaceae Pseudolarix plant golden larch.The property of medicine: root bark is irregular strip, distortion and slightly rolling up, not of uniform size, matter is tough, feeble QI, acrid in the mouth, hardship, warm in nature.Composition: root bark contains pseudolaric acid B, betulic acid, myricetin, amaron alcohol A and B etc.Find according to modern pharmacological research, this medical instrument has effect of antifungal, anticancer, expelling wind and removing dampness, killing parasites for relieving itching, for eczema, and neurodermatitis.
Cortex Meliae: have another name called chinaberry veneer, Ramulus meliae skin is bark and the root bark of Meliaceae melia plant chinaberry and Fructus Toosendan.The property of medicine: dried bark is irregular block lamellar, channel-shaped or half drum, and matter is tough, not frangibility, odorless, and bitter in the mouth is cold in nature.Composition: containing Toosendanin, Melia azedarach L. terpene alcoholic lactone, Melia azedarach L. ketone, isochuanliansu etc.Find according to modern pharmacological research, this medical instrument has effect of anthelmintic, heat clearing away, dampness, for ascariasis, and rubella pruritus, the diseases such as eczema scabies.
Flos Lonicerae: modern study proves, Flos Lonicerae contains the pharmacological component such as chlorogenic acid, luteolin glycosides, stronger restraint is had to the various pathogens such as Hemolytic streptococcus, staphylococcus aureus and upper respiratory tract infection Causative virus etc., in addition also can enhancing immunity, antiearly pregnancy, hepatoprotective, antitumor, antiinflammatory, antipyretic, hemostasis (blood coagulation), suppress intestinal absorption cholesterol etc., its clinical application widely, can be used for the treatment of respiratory tract infection, bacillary dysentery, acute urinary, hypertension etc. more than 40 with other medicines compatibility and plant disease.
Ramulus Cinnamomi: its nature and flavor are pungent, sweet, temperature, enter lung, the heart, urinary bladder channel, cure mainly the conventional drugs for dispelling internal cold of interior cold, there is effect of complement sun, promoting blood circulation, warming the spleen and stomach, normal with invigorating the liver and kidney medicine, fill blood medicine compatibility, treats insufficiency of kidney-YANG, decline of the fire from the gate of life, cold extremities faint pulse, treat coldness and pain in the epigastrium, arthralgia due to cold lumbago with other drugs for dispelling internal cold compatibility, there is the effect of significantly analgesia and anti-cancer and cancer-preventing.Existing various wind dispelling oils medicine is if menthocamphorate, rheumatism wet goods are all containing cassia oil composition.Ramulus Cinnamomi energy diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation, supporing yang activating QI, dispersing cold for relieving pain.Main exterior syndrome due to wind-cold; Arthralgia due to cold-dampnes; Extreme cold of the limbs; Amenorrhea dysmenorrhea; Lump in the abdomen lumps; The thoracic obstruction; Cardiopalmus; Phlegm retention; Dysuria.For anemofrigid cold, coldness and pain in the epigastrium, cold in blood amenorrhea, arthralgia, phlegm retention, edema, cardiopalmus, renal mass.
Indigo Naturalis: have another name called Concha Meretricis Seu Cyclinae powder, indigo-blue flower, for the leaf of Acanthaceae Acanthaceous indigo platymiscium Acanthaceous indigo, Polygonaceae arsesmart polygonum tinctorium ait., pulse family anil Folium et Caulis Indigoferae Tinctoriae, Cruciferae Isatis indigotica Fort. platymiscium Isatis indigotica Fort. or stem and leaf are through processing obtained dried powder or agglomerate.The property of medicine: this product is navy blue powder, body is light, and easily fly upward, micro-have careless stink smell, salty in the mouth, cold in nature.Composition: its main component has indirubin, indigo.Find according to modern pharmacological research, this medical instrument has effect of antitumor, anti-inflammatory and antalgic, antiulcer, antibacterial, clearing away heat and cooling blood, removing toxic substances, and for the malicious macule of temperature, laryngopharynx swelling and pain, spits blood, epistaxis, the symptoms such as spitting of blood.
Herba Taraxaci: heat-clearing and toxic substances removing, diuresis eliminating stagnation.Control acute mastitis, lymphadenitis, scrofula, furuncle carbuncle toxin, acute conjunctivitis, cold, fever, acute tonsillitis, acute bronchitis, gastritis, hepatitis, cholecystitis, urinary tract infection.
Pulvis Talci: sweet, light, cold.Return bladder, lung, stomach warp.Function cures mainly: inducing diuresis for treating stranguria syndrome, clearing away summer-heat, damp eliminating sore.For pyretic stranguria, stranguria caused by urinary stone, urinates hot puckery pain, heat-damp in summer excessive thirst, damp and hot watery diarrhea; External treatment eczema, eczema, miliaria.
Folium Isatidis: bitter in the mouth, cold in nature.Gui Jing: return liver, the heart, stomach, spleen channel.Effect: heat-clearing and toxic substances removing, blood cooling and ecchymoses removing.Cure mainly: for the high hot excessive thirst of calentura; Coma; Macule; Spit blood; Epistaxis; Jaundice; Dysentery; Erysipelas; Sore throat; Aphtha; Mumps.
Radix Rhodiolae: nature and flavor: cold, sweet, puckery.Gui Jing: lung meridian.Function cures mainly: have QI invigorating lung heat clearing, Fructus Alpiniae Oxyphyllae is nourished heart, effect of hemostasis with astringents, dissipating blood stasis for subsidence of swelling.Cure mainly deficiency of vital energy and physically weak, after being ill fear of cold, shortness of breath and fatigue, cough due to lung-heat, spitting of blood, leucorrhea diarrhoea, traumatic injury etc.
Herba Hedyotidis Diffusae: its patent medicine bitter in the mouth, light, cold in nature.Primary efficacy is heat-clearing and toxic substances removing, medicinal powder for relieving pain knot, promoting urination to remove dampness.Outstanding kind treatment all kinds inflammation.In clinical practice, if find, Herba Hedyotidis Diffusae compatibility is proper, can treat various diseases.Another name: Herba Hedyotidis Diffusae, tang Huang, Serpentis needle grass, Radix Picriae felterrae, two leaf humulus, spend that cross grass, sharp knife grass, JIAMENGCAO, Herba Otteliae Alismoidis, Serpentis Lei are careless, crane SHECAO in vain.
Caulis Spatholobi: chicken sedan-chair rattan bitter but slightly sweet taste, warm in nature, returns liver, the heart, kidney channel; Caulis Spatholobi red complexion enters blood, and matter profit row is loose; There is relaxing muscles and tendons to promote blood circulation, effect of nourishing blood for regulating menstruation; Cure mainly rheumatic arthralgia, numb hand and foot, quadriplegia, menoxenia, blockage of menstruation, dysmenorrhea, amenorrhea, leukopenia.The waist gonalgia, rheumatic arthralgia, the numb limbs and tense tendons for the treatment of caused by rheumatism, the compatibilities such as normal and Flos Carthami Semen Persicae, Radix Paeoniae Rubra, Pheretima, the Radix Astragali, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae.Can be used for menoxenia, amenorrhea, dysmenorrhea, normal and Rhizoma Cyperi, Herba Leonuri are used together.
Poria: sweet in the mouth, light, property is put down.Gui Jing: GUIXIN, lung, spleen, kidney channel.Effect: promoting diuresis to eliminate damp pathogen, spleen invigorating, mind calming.
Cure mainly: for edema oliguria, phlegm retention vertigo and palpitation, insufficiency of the spleen lack of appetite, have loose bowels in loose stool, irritability, palpitation with fear insomnia.
Herba Violae: heat-clearing and toxic substances removing.Control the high heat of epidemic febrile disease irritated, influenza, infectious hepatitis, nephritis, scrofula, parotitis, furuncle and other pyogenic infection.
Fructus Toosendan: return liver, small intestinal, urinary bladder channel.Effect: soothing the liverly to expel the heat-evil, promoting the circulation of QI to relieve pain, parasite killing.Cure mainly: for pathogenic fire derived from stagnation of liver-QI, the breast side of body, abdominal distention, hernia pain, abdominal pain due to worm stagnation.
Herba Menthae: Herba Menthae is one of Chinese conventional Chinese medicine.It is pungent cool property sweating antipyretic medicine, controls influenza, the disease such as headache, conjunctival congestion, fever of the body, throat, dental bed swell and ache.External can training the mind dysmenorrhoea, skin pruritus, erythra and eczema etc.Usually with Herba Menthae for tea, clear away heart-fire improving eyesight.
Radix Sophorae Tonkinensis: be the dry root welding technology of leguminous plant Sophora tonkinensis Gagnep..It is bitter, cold; Poisonous.Have heat-clearing and toxic substances removing, effect of detumescence sore-throat relieving, is usually used in fire-toxin and pents up, tonsillitis sore throat, laryngopharynx swelling and pain, gingivitis, aphtha of the mouth and tongue.
Radix et Rhizoma Dysosmatis: be the root and rhizome of Berberidaceae Dysosma plant Radix et Rhizoma Dysosmatis, Dysosma Pleiantha and dysosma veitchii Fu.Composition: 1. Radix et Rhizoma Dysosmatis rhizome is containing lignanoid: podophyllotoxin, picropodophyllin; Flavonoid: diphyllin kaempferol, Quercetin etc.2. Dysosma Pleiantha rhizome is containing lignanoid: podophyllotoxin, dehydropodophyllotoxin, podophyllotoxone etc.3. dysosma veitchii Fu root is containing deoxypodophyllotoxin ,-peltain, podophyllotoxin, kaempferol-3--D-Glucose glycosides, glucose, sucrose and-sitosterol.The property of medicine: bitter, pungent, temperature.Poisonous.Return lung, Liver Channel.Function cures mainly: removing toxic substances of reducing phlegm, eliminating stasis and resolving masses.Cure mainly cough, laryngopharynx swelling and pain, scrofula, goiter, nameless gall, herpes zoster, venom, traumatic injury, rheumatic arthralgia.
Herba Agerati Conyzoidis: be the herb of Compositae Ageratum plant Ageratum conyzoides.Composition: herb is containing flavonoid: Herba Agerati Conyzoidis flavone A, B, C, Nobiletin, senensetin, lindera pyrite B, etc.Alkaloid: Lycopodium clavatum amine, Echinatin.Triterpenoid compound: freidelin.Sterols: stigmasterol etc.Volatile oil: Herba Agerati Conyzoidis chromene, coumarin etc.Aerial parts contains chromene class: 7-methoxyl group-2,2-dimethyl chromogen alkene, 7,8-dimethoxy-2 etc.The property of medicine: micro-hardship, pungent, cool.Function cures mainly: heat-clearing and toxic substances removing, hemostasis, pain relieving.Cure mainly cold, fever, laryngopharynx swelling and pain, aphtha of the mouth and tongue, spitting of blood, epistaxis, metrorrhagia, epigastric pain, rheumatic arthralgia, traumatic injury, traumatic hemorrhage, thrush, carbuncle furuncle, eczema pruritus.
Aloe juice: moisturizing: be rich in native physiological water, mineral and lignin, permeability is extremely strong, as skin bottommost layer through as sponge sucks in water, directly moisture needed for supplementary skin, is the skin moisturizing product that can not be substituted.Brighten moisturizing: be rich in several amino acids and natural whiting Moisture factor, can be directly absorbed by the skin, decompose and conversion pigmentation, reach nature moisturizing whitening.Defying age: be rich in monosaccharide and polysaccharide, vitamin and mineral, have obvious therapeutic effect to the aging of cell, reduces the generation of wrinkle.Antiinflammatory, sterilization, mosquito proof are bitten, pain relieving, toxin expelling element: be rich in aloe-emodin and Anthraquinone Complex, external application, extremely strong to promotion wound-healing abilities, do not stay bar trace after extensive wound healing; Repair damaged skin, the irritating acne for the treatment of teenager and acne, and the impression that acne and acne stay, evident in efficacy.
The present composition is based on the principle of traditional Chinese medical herbal treatment psoriasis pustulosa.The Chinese medicinal material selected has toxin expelling, removing heat from blood, the effect of heat of dispelling, and cheap, and life-time service also can not cause the financial burden of patient, is treat the ideal medicine of psoriasis pustulosa.
Detailed description of the invention
Describe technical scheme of the present invention in detail below in conjunction with embodiment and experimental example, but protection domain is not by this restriction.
embodiment 1: a kind of compositions for the treatment of psoriasis pustulosa, take off the primary raw material stating weight proportion and be prepared from (getting 10g for every part): Cortex Pseudolaricis 4.5 grams, Cortex Meliae 4.5 grams, Flos Lonicerae 3 grams, Ramulus Cinnamomi 3 grams, Indigo Naturalis 3 grams, Herba Taraxaci 4.5 grams, Pulvis Talci 0.9 gram, Folium Isatidis 9 grams, Radix Rhodiolae 9 grams, Herba Hedyotidis Diffusae 6 grams, Caulis Spatholobi 6 grams, 6 grams, Poria, Herba Violae 6 grams, Fructus Toosendan 9 grams, Herba Menthae 9 grams, Radix Sophorae Tonkinensis 4 grams, Radix et Rhizoma Dysosmatis 3 grams, Herba Agerati Conyzoidis 9 grams, Aloe juice 20 parts.
The preparation method of the compositions of above-mentioned treatment psoriasis pustulosa, step is as follows:
1. Cortex Pseudolaricis, Cortex Meliae, Flos Lonicerae, Ramulus Cinnamomi, Herba Taraxaci, Folium Isatidis and Herba Menthae are together shredded, 14 minutes are soaked with light salt brine, filter, the soaked crude drug hot water of 90 DEG C scalds twice, is placed in preheated container, repeatedly stir-fry 2 minutes, cease fire, put into the vinegar of crude drug weight 0.2 times, mixing, continue to stir-fry 5 minutes, drying in the air coolly grinds to form smalls to cross 80 mesh sieves stand-by;
2. by step 1. gained smalls and Indigo Naturalis and Pulvis Talci mix and add Aloe juice, mix thoroughly clockwise, bottle and obtain medicine for external use;
3. with the warm water soaking 33 minutes of 30 DEG C in container Radix Rhodiolae, Herba Hedyotidis Diffusae, Caulis Spatholobi, Poria, Herba Violae, Fructus Toosendan, Radix Sophorae Tonkinensis, Radix et Rhizoma Dysosmatis and Herba Agerati Conyzoidis being placed in non iron, decoct twice, each is all first be fried open with high heat, turning 10 minutes at a simmer, filter, twice filtrate mixing, filtering residue is stand-by;
4. by step 3. gained filtering residue be placed in transparent vessel, add the rice wine of raw material weight 2 times, brewed 2 hours, filter, filtering residue is fried to crisp, grind to form smalls and step 3. gained filtrate mix, decoct and stir into thick paste and put into Mel and stir evenly, repeatedly rub, be twisted into medicated strip, cutting in bulk, is kneaded into grain, is prepared into capsule namely obtains oral medicine according to the processing technique subpackage of capsule.
model case one:gold XX, female, 40 years old, people from Linyi.Symptom: head has point erythema, scurf, also there is erythema, the scurf of size as copper coin afterwards with it, symptom develops into whole body very soon subsequently at property aseptic pimple for yellow-white shallow, and the erythema of extremity, scurf are ined succession picture map, and pruritus is hard to bear, scratching and grab rear bloodstained, painful very much, is psoriasis pustulosa through hospital diagnosis, the money flower very much for the treatment of, but Relapse rate difficulty is more.
Use embodiment 1 resulting composition, orally add external, use same day pruritis to alleviate; Use 10 days scurfs obviously to reduce, pruritis disappears, and pimple alleviates the disappearance had; Two weeks scurf is used to disappear more than half; Use again the present composition to consolidate 10 days, drug withdrawal is so far without recurrence.
embodiment 2:treat a compositions for psoriasis pustulosa, take off the primary raw material stating weight proportion and be prepared from (getting 10g for every part): Cortex Pseudolaricis 5 grams, Cortex Meliae 5 grams, Flos Lonicerae 3.5 grams, Ramulus Cinnamomi 3.5 grams, Indigo Naturalis 3.5 grams, Herba Taraxaci 5 grams, Pulvis Talci 1.0 grams, Folium Isatidis 12 grams, Radix Rhodiolae 9.5 grams, Herba Hedyotidis Diffusae 7 grams, Caulis Spatholobi 7 grams, 7 grams, Poria, Herba Violae 8 grams, Fructus Toosendan 10 grams, Herba Menthae 10 grams, Radix Sophorae Tonkinensis 5 grams, Radix et Rhizoma Dysosmatis 4 grams, Herba Agerati Conyzoidis 10 grams, Aloe juice 40 parts.
The preparation method of the compositions of above-mentioned treatment psoriasis pustulosa, step is as follows:
1. Cortex Pseudolaricis, Cortex Meliae, Flos Lonicerae, Ramulus Cinnamomi, Herba Taraxaci, Folium Isatidis and Herba Menthae are together shredded, 26 minutes are soaked with light salt brine, filter, the soaked crude drug hot water of 100 DEG C scalds twice, is placed in preheated container, repeatedly stir-fry 6 minutes, cease fire, put into the vinegar of crude drug weight 0.4 times, mixing, continue to stir-fry 12 minutes, drying in the air coolly grinds to form smalls to cross 120 mesh sieves stand-by;
2. by step 1. gained smalls and Indigo Naturalis and Pulvis Talci mix and add Aloe juice, mix thoroughly clockwise, bottle and obtain medicine for external use;
3. with the warm water soaking 44 minutes of 40 DEG C in container Radix Rhodiolae, Herba Hedyotidis Diffusae, Caulis Spatholobi, Poria, Herba Violae, Fructus Toosendan, Radix Sophorae Tonkinensis, Radix et Rhizoma Dysosmatis and Herba Agerati Conyzoidis being placed in non iron, decoct twice, each is all first be fried open with high heat, turning 20 minutes at a simmer, filter, twice filtrate mixing, filtering residue is stand-by;
4. by step 3. gained filtering residue be placed in transparent vessel, add the rice wine of raw material weight 4 times, brewed 4 hours, filter, filtering residue is fried to crisp, grind to form smalls and step 3. gained filtrate mix, decoct and stir into thick paste and put into Mel and stir evenly, repeatedly rub, be twisted into medicated strip, cutting in bulk, is kneaded into grain, is prepared into capsule namely obtains oral medicine according to the processing technique subpackage of capsule.
embodiment 3:treat a compositions for psoriasis pustulosa, take off the primary raw material stating weight proportion and be prepared from (getting 10g for every part): Cortex Pseudolaricis 8 grams, Cortex Meliae 8 grams, Flos Lonicerae 5 grams, Ramulus Cinnamomi 5 grams, Indigo Naturalis 5 grams, Herba Taraxaci 8 grams, Pulvis Talci 1.4 grams, Folium Isatidis 25 grams, Radix Rhodiolae 11 grams, Herba Hedyotidis Diffusae 11 grams, Caulis Spatholobi 11 grams, 11 grams, Poria, Herba Violae 12 grams, Fructus Toosendan 13 grams, Herba Menthae 14 grams, Radix Sophorae Tonkinensis 8 grams, Radix et Rhizoma Dysosmatis 10 grams, Herba Agerati Conyzoidis 14 grams, Aloe juice 25 parts.
The preparation method of the compositions of above-mentioned treatment psoriasis pustulosa, step is as follows:
1. Cortex Pseudolaricis, Cortex Meliae, Flos Lonicerae, Ramulus Cinnamomi, Herba Taraxaci, Folium Isatidis and Herba Menthae are together shredded, 18 minutes are soaked with light salt brine, filter, the soaked crude drug hot water of 93 DEG C scalds twice, is placed in preheated container, repeatedly stir-fry 3 minutes, cease fire, put into the vinegar of crude drug weight 0.25 times, mixing, continue to stir-fry 7 minutes, drying in the air coolly grinds to form smalls to cross 90 mesh sieves stand-by;
2. by step 1. gained smalls and Indigo Naturalis and Pulvis Talci mix and add Aloe juice, mix thoroughly clockwise, bottle and obtain medicine for external use;
3. with the warm water soaking 38 minutes of 33 DEG C in container Radix Rhodiolae, Herba Hedyotidis Diffusae, Caulis Spatholobi, Poria, Herba Violae, Fructus Toosendan, Radix Sophorae Tonkinensis, Radix et Rhizoma Dysosmatis and Herba Agerati Conyzoidis being placed in non iron, decoct twice, each is all first be fried open with high heat, turning 13 minutes at a simmer, filter, twice filtrate mixing, filtering residue is stand-by;
4. by step 3. gained filtering residue be placed in transparent vessel, add the rice wine of raw material weight 2.5 times, brewed 2.5 hours, filter, filtering residue is fried to crisp, grind to form smalls and step 3. gained filtrate mix, decoct and stir into thick paste and put into Mel and stir evenly, repeatedly rub, be twisted into medicated strip, cutting in bulk, is kneaded into grain, is prepared into capsule namely obtains oral medicine according to the processing technique subpackage of capsule.
embodiment 4: a kind of compositions for the treatment of psoriasis pustulosa, take off the primary raw material stating weight proportion and be prepared from (getting 10g for every part): Cortex Pseudolaricis 9 grams, Cortex Meliae 9 grams, Flos Lonicerae 6 grams, Ramulus Cinnamomi 6 grams, Indigo Naturalis 6 grams, Herba Taraxaci 9 grams, Pulvis Talci 1.5 grams, Folium Isatidis 30 grams, Radix Rhodiolae 12 grams, Herba Hedyotidis Diffusae 12 grams, Caulis Spatholobi 12 grams, 12 grams, Poria, Herba Violae 15 grams, Fructus Toosendan 15 grams, Herba Menthae 15 grams, Radix Sophorae Tonkinensis 9 grams, Radix et Rhizoma Dysosmatis 12 grams, Herba Agerati Conyzoidis 15 grams, Aloe juice 35 parts.
The preparation method of the compositions of above-mentioned treatment psoriasis pustulosa, step is as follows:
1. Cortex Pseudolaricis, Cortex Meliae, Flos Lonicerae, Ramulus Cinnamomi, Herba Taraxaci, Folium Isatidis and Herba Menthae are together shredded, 22 minutes are soaked with light salt brine, filter, the soaked crude drug hot water of 98 DEG C scalds twice, is placed in preheated container, repeatedly stir-fry 5 minutes, cease fire, put into the vinegar of crude drug weight 0.35 times, mixing, continue to stir-fry 10 minutes, drying in the air coolly grinds to form smalls to cross 110 mesh sieves stand-by;
2. by step 1. gained smalls and Indigo Naturalis and Pulvis Talci mix and add Aloe juice, mix thoroughly clockwise, bottle and obtain medicine for external use;
3. with the warm water soaking 40 minutes of 38 DEG C in container Radix Rhodiolae, Herba Hedyotidis Diffusae, Caulis Spatholobi, Poria, Herba Violae, Fructus Toosendan, Radix Sophorae Tonkinensis, Radix et Rhizoma Dysosmatis and Herba Agerati Conyzoidis being placed in non iron, decoct twice, each is all first be fried open with high heat, turning 18 minutes at a simmer, filter, twice filtrate mixing, filtering residue is stand-by;
4. by step 3. gained filtering residue be placed in transparent vessel, add the rice wine of raw material weight 3.5 times, brewed 3.5 hours, filter, filtering residue is fried to crisp, grind to form smalls and step 3. gained filtrate mix, decoct and stir into thick paste and put into Mel and stir evenly, repeatedly rub, be twisted into medicated strip, cutting in bulk, is kneaded into grain, is prepared into capsule namely obtains oral medicine according to the processing technique subpackage of capsule.
model case two:liu XX, female, 25 years old, people from Linyi, originally the pimple just having some slight on ancon and arm, afterwards due to malpractice, caused that sb.'s illness took a turn for the worse in a short period of time, present whole body is all red pimple, surface has multilamellar silvery white flakey scurf, pruritus, pain from head to foot, whole body desquamation, local, with skin lesion (festering) phenomenon, goes examination in hospital to be diagnosed as psoriasis pustulosa.
Use embodiment 4 resulting composition, orally add external, use the same day, the itch symptom of pain of skin focus place is obviously improved; Use 3 days skin lesion (festering) positions to be clearly better, dermatitis, pimple etc. are controlled; Use 7 days skin lesion (festering) positions to heal completely, dermatitis, pimple disappear most; Use 15 days, dermatitis, pimple disappear completely, recover; Rear suggestion its singly take medicine and consolidate 5 days, drug withdrawal so far without recurrence, appearance without any side effects between the operating period.
embodiment 5:treat a compositions for psoriasis pustulosa, take off the primary raw material stating weight proportion and be prepared from (getting 10g for every part): Cortex Pseudolaricis 7 parts, Cortex Meliae 7 parts, Flos Lonicerae 4 parts, Ramulus Cinnamomi 4 parts, Indigo Naturalis 4 parts, Herba Taraxaci 6 parts, Pulvis Talci 1.2 parts, Folium Isatidis 20 parts, Radix Rhodiolae 10 parts, Herba Hedyotidis Diffusae 9 parts, Caulis Spatholobi 8 parts, 9 parts, Poria, Herba Violae 10 parts, Fructus Toosendan 12 parts, Herba Menthae 12 parts, Radix Sophorae Tonkinensis 6 parts, Radix et Rhizoma Dysosmatis 6 parts, Herba Agerati Conyzoidis 12 parts, Aloe juice 30 parts.
The preparation method of the compositions of above-mentioned treatment psoriasis pustulosa, step is as follows:
1. Cortex Pseudolaricis, Cortex Meliae, Flos Lonicerae, Ramulus Cinnamomi, Herba Taraxaci, Folium Isatidis and Herba Menthae are together shredded, 20 minutes are soaked with light salt brine, filter, the soaked crude drug hot water of 95 DEG C scalds twice, is placed in preheated container, repeatedly stir-fry 4 minutes, cease fire, put into the vinegar of crude drug weight 0.3 times, mixing, continue to stir-fry 8 minutes, drying in the air coolly grinds to form smalls to cross 100 mesh sieves stand-by;
2. by step 1. gained smalls and Indigo Naturalis and Pulvis Talci mix and add Aloe juice, mix thoroughly clockwise, bottle and obtain medicine for external use;
3. with the warm water soaking 39 minutes of 35 DEG C in container Radix Rhodiolae, Herba Hedyotidis Diffusae, Caulis Spatholobi, Poria, Herba Violae, Fructus Toosendan, Radix Sophorae Tonkinensis, Radix et Rhizoma Dysosmatis and Herba Agerati Conyzoidis being placed in non iron, decoct twice, each is all first be fried open with high heat, turning 15 minutes at a simmer, filter, twice filtrate mixing, filtering residue is stand-by;
4. by step 3. gained filtering residue be placed in transparent vessel, add the rice wine of raw material weight 3 times, brewed 3 hours, filter, filtering residue is fried to crisp, grind to form smalls and step 3. gained filtrate mix, decoct and stir into thick paste and put into Mel and stir evenly, repeatedly rub, be twisted into medicated strip, cutting in bulk, is kneaded into grain, is prepared into capsule namely obtains oral medicine according to the processing technique subpackage of capsule.
Using method: for making the present invention reach optimum therapeuticing effect, the present composition, external used medicine gets 3g at every turn, mixes thoroughly with the hot water of 10g, accounts for wiping affected part by swab stick, each 2 of oral capsule, three times on the one, warm water delivery service.
experimental example 1:the clinical practice of the drop of embodiment 5 gained treatment psoriasis pustulosa: screen 300 routine patients in 4 hospitals, before test 2 days, Continuous Observation is carried out to this crowd, record symptom and change, be divided into two groups at random, experimental group and matched group, experimental group uses embodiment 5 products obtained therefrom, and matched group uses other medicine.
Curative effect situation criterion: effectively: after taking this product, malaise symptoms disappears; Invalid: after taking this product, health is unchanged.Result is as shown in table 1.
Table 1:
Prove through clinical trial, the present composition is on treatment psoriasis pustulosa, effective percentage is 98%, cure rate is 95%, uses the present composition, can effectively alleviate the pruritis caused by psoriasis pustulosa, alleviate safely the misery of patient fast, and relapse rate is low, not occurring a routine side effect case in clinical, is a kind of compositions of safer effective treatment psoriasis pustulosa.
Claims (10)
1. treat the compositions of psoriasis pustulosa for one kind, it is characterized in that: take off the primary raw material stating weight proportion and be prepared from: Cortex Pseudolaricis 4.5-9 part, Cortex Meliae 4.5-9 part, Flos Lonicerae 3-6 part, Ramulus Cinnamomi 3-6 part, Indigo Naturalis 3-6 part, Herba Taraxaci 4.5-9 part, Pulvis Talci 0.9-1.5 part, Folium Isatidis 9-30 part is (preferred, Folium Isatidis 9.5-29.5 part), Radix Rhodiolae 9-12 part, Herba Hedyotidis Diffusae 6-12 part, Caulis Spatholobi 6-12 part, Poria 6-12 part, Herba Violae 6-15 part, Fructus Toosendan 9-15 part, Herba Menthae 9-15 part, Radix Sophorae Tonkinensis 4-9 part, Radix et Rhizoma Dysosmatis 3-12 part, Herba Agerati Conyzoidis 9-15 part, Aloe juice 20-40 part.
2. the compositions for the treatment of psoriasis pustulosa according to claim 1, it is characterized in that: take off the primary raw material stating weight proportion and be prepared from: Cortex Pseudolaricis 5-8 part, Cortex Meliae 5-8 part, Flos Lonicerae 3.5-5 part, Ramulus Cinnamomi 3.5-5 part, Indigo Naturalis 3.5-5 part, Herba Taraxaci 5-8 part, Pulvis Talci 1.0-1.4 part, Folium Isatidis 12-25 part, Radix Rhodiolae 9.5-11 part, Herba Hedyotidis Diffusae 7-11 part, Caulis Spatholobi 7-11 part, Poria 7-11 part, Herba Violae 8-12 part, Fructus Toosendan 10-13 part, Herba Menthae 10-14 part, Radix Sophorae Tonkinensis 5-8 part, Radix et Rhizoma Dysosmatis 4-10 part, Herba Agerati Conyzoidis 10-14 part, Aloe juice 25-35 part.
3. the compositions for the treatment of psoriasis pustulosa according to claim 1, is characterized in that: take off the primary raw material stating weight proportion and be prepared from: Cortex Pseudolaricis 7 parts, Cortex Meliae 7 parts, Flos Lonicerae 4 parts, Ramulus Cinnamomi 4 parts, Indigo Naturalis 4 parts, Herba Taraxaci 6 parts, Pulvis Talci 1.2 parts, Folium Isatidis 20 parts, Radix Rhodiolae 10 parts, Herba Hedyotidis Diffusae 9 parts, Caulis Spatholobi 8 parts, 9 parts, Poria, Herba Violae 10 parts, Fructus Toosendan 12 parts, Herba Menthae 12 parts, Radix Sophorae Tonkinensis 6 parts, Radix et Rhizoma Dysosmatis 6 parts, Herba Agerati Conyzoidis 12 parts, Aloe juice 30 parts.
4. the preparation method of composition of the treatment psoriasis pustulosa according to any one of claim 1-3, is characterized in that: step is as follows:
1. Cortex Pseudolaricis, Cortex Meliae, Flos Lonicerae, Ramulus Cinnamomi, Herba Taraxaci, Folium Isatidis and Herba Menthae are together shredded, 14-26 minute is soaked with light salt brine, filter, the hot water of soaked crude drug 90-100 DEG C scalds twice, is placed in preheated container, stir-fry 2-6 minute repeatedly, cease fire, put into crude drug weight 0.2-0.4 vinegar doubly, mixing, continue the 5-12 minute that stir-fries, drying in the air coolly grinds to form smalls to cross 80-120 mesh sieve stand-by;
2. by step 1. gained smalls and Indigo Naturalis and Pulvis Talci mix and add Aloe juice, mix thoroughly clockwise, bottle and obtain medicine for external use;
3. with the warm water soaking 33-44 minute of 30-40 DEG C in container Radix Rhodiolae, Herba Hedyotidis Diffusae, Caulis Spatholobi, Poria, Herba Violae, Fructus Toosendan, Radix Sophorae Tonkinensis, Radix et Rhizoma Dysosmatis and Herba Agerati Conyzoidis being placed in non iron, decoct twice, each is all first be fried open with high heat, turning 10-20 minute at a simmer, filter, twice filtrate mixing, filtering residue is stand-by;
4. by step 3. gained filtering residue be placed in transparent vessel, add raw material weight 2-4 rice wine doubly, brewed 2-4 hour, filter, filtering residue is fried to crisp, grind to form smalls and step 3. gained filtrate mix, decoct and stir into thick paste and put into Mel and stir evenly, repeatedly rub, be twisted into medicated strip, cutting in bulk, is kneaded into grain, is prepared into capsule namely obtains oral medicine according to the processing technique subpackage of capsule.
5. preparation method according to claim 4, it is characterized in that: 1. step soaks 18-22 minute with light salt brine, filter, the hot water of soaked crude drug 93-98 DEG C scalds and (preferably soaks 20 minutes with light salt brine twice, filter, the soaked crude drug hot water of 95 DEG C scalds twice).
6. preparation method according to claim 4, is characterized in that: 1. step stir-fries 3-5 minute repeatedly, ceases fire, and puts into crude drug weight 0.25-0.35 vinegar doubly (preferably repeatedly stir-fry 4 minutes, cease fire, put into the vinegar of crude drug weight 0.3 times).
7. preparation method according to claim 4, it is characterized in that: it is characterized in that, 1. step continues the 7-10 minute that stir-fries, and the cool smalls that grinds to form that dries in the air crosses 90-110 mesh sieve stand-by (preferably continue to stir-fry 8 minutes, dry in the air cool grind to form smalls to cross 100 mesh sieves stand-by).
8. preparation method according to claim 4, is characterized in that: it is characterized in that, with 33-38 DEG C warm water soaking 38-40 minute (being preferably placed in the interior warm water soaking with 35 DEG C of the container of non iron 39 minutes) in the container that 3. step is placed in non iron.
9. preparation method according to claim 4, is characterized in that: it is characterized in that, 3. step is all first be fried open with high heat at every turn, is turning 13-18 at a simmer minute (be all preferably first be fried open with high heat at every turn, turning 15 minutes at a simmer).
10. preparation method according to claim 4, is characterized in that: it is characterized in that, 4. step adds raw material weight 2.5-3.5 rice wine doubly, brewed 2.5-3.5 hour (preferably adding the rice wine of raw material weight 3 times, brewed 3 hours).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610023124.0A CN105434793A (en) | 2016-01-14 | 2016-01-14 | Composition for treating psoriasis pustulose and preparation method for composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610023124.0A CN105434793A (en) | 2016-01-14 | 2016-01-14 | Composition for treating psoriasis pustulose and preparation method for composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105434793A true CN105434793A (en) | 2016-03-30 |
Family
ID=55545722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610023124.0A Pending CN105434793A (en) | 2016-01-14 | 2016-01-14 | Composition for treating psoriasis pustulose and preparation method for composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105434793A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106177554A (en) * | 2016-08-17 | 2016-12-07 | 施泽晶 | A kind of Chinese medicine composition treating fire derived from stagnation of liver-QI type dermatitis and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103110851A (en) * | 2013-01-17 | 2013-05-22 | 刘凤华 | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof |
CN103566246A (en) * | 2012-08-03 | 2014-02-12 | 天津太平洋制药有限公司 | Drug for treating psoriasis |
CN104147445A (en) * | 2013-01-17 | 2014-11-19 | 刘凤华 | Traditional Chinese medicine for treating psoriasis and preparation method thereof |
CN104147446A (en) * | 2013-01-17 | 2014-11-19 | 刘凤华 | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof |
CN104162051A (en) * | 2013-01-17 | 2014-11-26 | 刘凤华 | Preparation method of traditional Chinese medicine for treating psoriasis |
-
2016
- 2016-01-14 CN CN201610023124.0A patent/CN105434793A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103566246A (en) * | 2012-08-03 | 2014-02-12 | 天津太平洋制药有限公司 | Drug for treating psoriasis |
CN103110851A (en) * | 2013-01-17 | 2013-05-22 | 刘凤华 | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof |
CN104147445A (en) * | 2013-01-17 | 2014-11-19 | 刘凤华 | Traditional Chinese medicine for treating psoriasis and preparation method thereof |
CN104147446A (en) * | 2013-01-17 | 2014-11-19 | 刘凤华 | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof |
CN104162051A (en) * | 2013-01-17 | 2014-11-26 | 刘凤华 | Preparation method of traditional Chinese medicine for treating psoriasis |
Non-Patent Citations (3)
Title |
---|
刘云币等: "《中国历代中医格言大观》", 31 March 1992, 文汇出版社 * |
孙丽蕴等: "《当代中医皮肤科临床家丛书 第2辑 邓丙戌》", 30 September 2015, 中国医药科技出版社 * |
王玉华等: "辨证治疗银屑病200例疗效观察", 《山西中医》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106177554A (en) * | 2016-08-17 | 2016-12-07 | 施泽晶 | A kind of Chinese medicine composition treating fire derived from stagnation of liver-QI type dermatitis and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101502588B (en) | Composition for beauty treatment and removing blain and method for preparing the same | |
CN104208245B (en) | Tinea manus and pedis Traditional Chinese medicine medicated bath and preparation method | |
CN104083498A (en) | Rhinitis ointment | |
CN104524287A (en) | Traditional Chinese medicinal composition for treating anaphylactoid purpura and preparation method of traditional Chinese medicinal composition | |
CN104435326A (en) | Traditional Chinese medicine preparation for treating acute mastitis | |
CN105434793A (en) | Composition for treating psoriasis pustulose and preparation method for composition | |
CN104491371A (en) | Swelling and lump removing plaster for chronic breast tuberculosis and preparation method | |
CN104436109A (en) | Traditional Chinese medicine preparation for treating scleroderma | |
CN105169278A (en) | Dandelion oral liquid capable of protecting liver and benefiting gallbladder and preparation method thereof | |
CN104771585A (en) | Traditional Chinese medicine composition for treating acute nephritis and preparation method thereof | |
CN104398741A (en) | Traditional Chinese medicinal preparation for treating osteomyelitis | |
CN104435162A (en) | Oral traditional Chinese medicine preparation for treating viral pneumonia | |
CN104225094A (en) | Traditional Chinese medicine preparation for treating Behcet's syndrome | |
CN105770760A (en) | Preparation for treating gastric ulcer and preparation method thereof | |
CN104666833A (en) | Chinese medicinal composition for treating uterine fibroids and preparation method thereof | |
CN105055653A (en) | Medicine decoction for treating pulpitis and preparation method thereof | |
CN105213749A (en) | Be used for the treatment of osteoporotic preparation and method for making | |
CN105079425A (en) | Composition preparation for treating infantile hand-foot-mouth disease, and preparation method of composition preparation | |
CN104524035A (en) | Traditional Chinese medicine for treating prosopospasm and preparation method thereof | |
CN105012789A (en) | Composition for treating cervical cancer and preparation method thereof | |
CN104606638A (en) | Medicine for treating damp-heat type acute eczema and preparation method thereof | |
CN103860976A (en) | Drug composition for treating infantile dermatitis | |
CN104784666A (en) | Traditional Chinese medicine ointment for orthopedic nursing | |
CN104383361A (en) | Traditional Chinese medicine preparation for treating acute infectious hepatitis | |
CN104435853A (en) | Traditional Chinese medicine composition for treating coronary heart disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160330 |